This browser does not support the Video element.
Doctors using new technology to help treat patients
Imagine knowing you're at risk for a major illness years before you ever show symptoms. A healthcare company, Fountain Life, is using artificial intelligence, full-body MRIs, and advanced biomarker tracking to find early warning signs.
HOUSTON - The medical industry is shifting toward data-driven preventative diagnostics powered by automated technology.
Fountain Life integrates neuro-imaging, cardiac scanning, and genomic profiling to build an automated, personalized health map. The technology looks closely at your cells to find early warning signs.
From there, it creates a personal plan using everyday changes like better sleep and nutrition or specific medications to stop and even reverse issues before someone feels sick.
Blending technology with healthcare
Why you should care:
The traditional medical model focuses on treating illnesses after symptoms appear, which can make conditions harder to manage and increase healthcare costs. Using AI tools to catch risk factors early allows individuals to address potential issues before they develop into chronic diseases.
By the numbers:
- 4 to 5 hours are required to complete a full screening panel, replacing up to 26 individual medical tests.
- 95: The target age that modern longevity science believes an average individual can reach while remaining completely healthy and active.
- $500: The entry-level cost for newly launched tier options, shifting the platform away from its original high-fee exclusive membership model.
Big picture view:
Combining advanced body scans with artificial intelligence is changing the way medicine works. Instead of giving everyone the same basic treatments, doctors can look at everything from your gut health to your blood vessels all at once to create a health plan tailored exactly to your body.
Fountain Life's new diagnostic options
What's next:
Fountain Life is scaling its consumer footprint by introducing localized diagnostic options. Patients will soon be able to visit local partner blood draw stations to collect metabolic samples. The resulting data will feed directly into the company's secure AI engine, allowing users to track structural changes and ongoing biomarker trends remotely.
Dig deeper:
To review the diagnostic platforms, learn about local testing centers, or explore specialized clinical longevity programs, check the company's official resources at fountainlife.com.
The Source: FOX 26 Anchor and Medical Reporter Melissa Wilson interviewed Fountain Life CEO William Kapp to gather information for this story.